Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Henoch-Schönlein purpura.

Abraham Gedalia1

  • 1Department of Pediatrics, Louisiana State University Health Sciences Center and Children's Hospital, 1542 Tulane Avenue, T8-1, New Orleans, LA 70112, USA. a61543@pol.net

Current Rheumatology Reports
|May 12, 2004
PubMed
Summary

Henoch-Schönlein purpura (HSP) is an immunoglobulin A-mediated vasculitis affecting multiple organs, most common in children. Steroids may treat severe HSP symptoms, but long-term outcomes depend on kidney and neurological involvement.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Kawasaki Disease: an Update.

Current rheumatology reports·2020
Same author

Refractory Pain and Swelling of the Left Wrist in a 7-Year-Old Female.

Clinical pediatrics·2019
Same author

6-Year-Old With Severe Hypertension.

Clinical pediatrics·2017
Same author

A 19-Year-Old Woman With Increased Urinary Frequency, Abdominal and Back Pain.

Clinical pediatrics·2016
Same author

Disability in Children and Adolescents With Irritable Bowel Syndrome and/or Fibromyalgia.

Journal of pediatric gastroenterology and nutrition·2015
Same author

Severe Musculoskeletal Pain in a Patient With Systemic Lupus Erythematosus.

Clinical pediatrics·2015

Area of Science:

  • Immunology
  • Pediatrics
  • Rheumatology

Background:

  • Henoch-Schönlein purpura (HSP) is a common childhood vasculitis characterized by immunoglobulin A deposition.
  • It typically affects the skin, joints, gastrointestinal tract, and kidneys, often presenting with a distinctive rash on the lower extremities and buttocks.
  • Diagnosis in children is usually clinical, but skin biopsy may be necessary in atypical cases, including adults and very young children.

Purpose of the Study:

  • To summarize the clinical presentation, diagnostic considerations, treatment modalities, and prognosis of Henoch-Schönlein purpura.
  • To highlight the role of corticosteroids in managing severe HSP manifestations.
  • To underscore the importance of monitoring for renal and neurological involvement due to potential long-term morbidity.

Main Methods:

  • Review of existing literature on Henoch-Schönlein purpura, including retrospective studies and clinical experience.
  • Analysis of diagnostic criteria and the utility of skin biopsy in different age groups.
  • Evaluation of treatment strategies for various HSP involvements and their supporting evidence.

Main Results:

  • HSP commonly affects children aged 3-10 years with a characteristic rash distribution, making biopsy often unnecessary in this group.
  • Skin biopsy is frequently required for diagnosis in adults and very young children due to atypical rash presentation.
  • Steroids are supported by retrospective data for severe gastrointestinal, renal, central nervous system, and testicular involvement.

Conclusions:

  • While HSP generally has a self-limited course and excellent prognosis, severe renal and neurological complications can lead to significant long-term morbidity.
  • Recurrences are common, occurring within weeks to several years after the initial episode.
  • Aggressive management with steroids, and potentially immunosuppressive agents or plasmapheresis for severe cases, is crucial for improving outcomes.

Related Experiment Videos